<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02108587</url>
  </required_header>
  <id_info>
    <org_study_id>CASE11811</org_study_id>
    <secondary_id>NCI-2014-00347</secondary_id>
    <secondary_id>CASE 11811</secondary_id>
    <secondary_id>P30CA043703</secondary_id>
    <nct_id>NCT02108587</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer</brief_title>
  <official_title>Staging of Upper Tract Urothelial Cancer With Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Case Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Case Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial studies how well optical coherence tomography works in staging patients&#xD;
      with upper-tract urothelial carcinomas. Staging describes the severity of a person's cancer&#xD;
      based on the size and/or extent (reach) of the original (primary) tumor and whether or not&#xD;
      cancer has spread in the body. It also helps the doctor plan the appropriate treatment.&#xD;
      Optical coherence tomography is a procedure that uses infrared light waves to give&#xD;
      three-dimensional pictures of structures inside tissues and organs. The pictures are made by&#xD;
      a computer linked to the light source. Optical coherence tomography may be effective in&#xD;
      staging patients with upper-tract urothelial carcinomas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To test the feasibility and imaging ability of optical coherence tomography (OCT) to stage&#xD;
      upper-tract urothelial carcinomas (UTUC).&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo optical coherence tomography over 10-15 minutes.&#xD;
&#xD;
      After completion of study, patients are followed up at 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding unavailable&#xD;
  </why_stopped>
  <start_date>December 2016</start_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of optical coherence tomography (OCT) images in staging upper-tract urothelial carcinomas (UTUC)</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Feasibility defined as the ability to relate the features associated with cancerous tissues in pathohistological analysis to the features in OCT images</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Imaging Analysis</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Number of cancerous images with at least one feature different from normal pathology slide</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Kidney/Urinary Cancer</condition>
  <arm_group>
    <arm_group_label>optical coherence tomography for diagnosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo optical coherence tomography over 10-15 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography</intervention_name>
    <description>Undergo optical coherence tomography</description>
    <arm_group_label>optical coherence tomography for diagnosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must have radiographic evidence of upper tract urothelial cancer by computed&#xD;
             tomography (CT), magnetic resonance imaging (MRI) or intravenous pyelogram (IVP) in&#xD;
             order to undergo this procedure&#xD;
&#xD;
          -  Patient who will undergo standard of care clinical staging for UTUC&#xD;
&#xD;
          -  Patient ability to read and comprehend the informed consent document&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who has a contraindication to endoscopy&#xD;
&#xD;
          -  Patient who is pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald Bodner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Comprehensive Cancer Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

